Abstract
Targeted toxins are fusion proteins that combine a targeting molecule that selectively binds to and enters tumor cells with a protein toxin that kills the target cells. These molecules represent an exciting approach to develop effective cancer-specific therapeutics that have few side effects on normal tissues and numerous such toxins are in various stages of pre-clinical and clinical development to treat a wide variety of tumors. In this review, we discuss this strategy, describe ways that the toxins activate the apoptosis machinery and discuss future developments in this field.
Original language | English (US) |
---|---|
Pages (from-to) | 19-25 |
Number of pages | 7 |
Journal | Apoptosis |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2004 |
Keywords
- Apoptosis
- Cancer treatment
- Chemotherapy
- Diphtheria toxin
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science
- Clinical Biochemistry
- Cell Biology
- Biochemistry, medical
- Cancer Research